Clinical trials
Uterine Cervical Neoplasms trials in Czechia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Recruiting | 7 |
| Active, not recruiting | 3 |
| Terminated | 3 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| General University Hospital, Prague | 3 |
| The Institute of Molecular and Translational Medicine, Czech Republic | 3 |
| AstraZeneca | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Seagen, a wholly owned subsidiary of Pfizer | 2 |
| AeskuLab Pathology Prague | 1 |
| Amgen | 1 |
| Centre Hospitalier Universitaire de Besancon | 1 |
| Charles University, Czech Republic | 1 |
| Institut Claudius Regaud | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Cervical Neoplasms | 25 |
| Ovarian Neoplasms | 4 |
| Papillomavirus Infections | 4 |
| Uterine Cervical Dysplasia | 4 |
| Biliary Tract Neoplasms | 3 |
| Endometrial Neoplasms | 3 |
| Urinary Bladder Neoplasms | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Colorectal Neoplasms | 2 |
| Neoplasm Metastasis | 2 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.